ResTORbio completes dosing in mid-stage study of RTB101 in respiratory tract infections; data readout next quarter; shares up 4% [Seeking Alpha]
RESTORBIO (TORC)
Last restorbio earnings: 3/12 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.restorbio.com/investor-resources/investor-faqi
Company Research
Source: Seeking Alpha
ResTORbio completes dosing in mid-stage study of RTB101 in respiratory tract infections; data readout next quarter; shares up 4%Relatively recent IPO resTORbio (TORC+3.6%)reports that it has completed dosing in aPhase 2b clinical trial assessing lead candidate RTB101, as monotherapy and in combination with Novartis'AFINITOR (everolimus), in reducing the incidence of respiratory tract infections in the elderly.The primary endpoint of the 652-subject study is the proportion of subjects with one or more respiratory tract infections through week 16. Topline data should be available next quarter.Previously:IPO approaches for resTORbio (Jan. 2)See all stocks on the move »Now read:BioSci Rounds Report: Improving Fundamentals To Catapult Omeros And Restorbio »
Show less
Read more
Impact Snapshot
Event Time:
TORC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TORC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TORC alerts
High impacting RESTORBIO news events
Weekly update
A roundup of the hottest topics